Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands

Vaccine

Volumn 26, Issue 52, 2008, Pages 6975-6979

  Meerveld Eggink, A ^a   de Weerdt, O ^a   Rijkers, G T ^a   van Velzen Blad, H ^a   Biesma, D H ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Asplenia; Infectious risks; Vaccination

Indexed keywords

ANTIBODY;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBODY BLOOD LEVEL; ARTICLE; ASPLENIA; AWARENESS; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NEISSERIA MENINGITIDIS; NETHERLANDS; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SPLEEN DISEASE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIBODIES, BACTERIAL; DATABASES, FACTUAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFECTION; MALE; MIDDLE AGED; NETHERLANDS; PATIENT EDUCATION AS TOPIC; PNEUMOCOCCAL VACCINES; QUESTIONNAIRES; RISK; SPLEEN; SPLENECTOMY; SPLENIC DISEASES; VACCINATION; YOUNG ADULT;

EID: 56649124647     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.052     Document Type: Article

References (26)

1. Waghorn D.J. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 54 3 (2001) 214-218
2. Centers for Disease control and prevention. Recommended Adult Immunization Schedule - United States, October 2007 - September 2008. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR QuickGuide 2007;56(41):Q1-Q4.
3. Working party of the British Committee for Standards in Haematology. Clinical Haematology Task Force. Guidelines for the prevention and treatment on infection in patients with an absent or dysfunctional spleen. BMJ 1996;312:430-434.
4. Spelman D. Prevention of overwhelming sepsis in asplenic patients: could do better. The Lancet 357 (2001) 2072
5. Newland A., Provan D., and Myint S. Preventing severe infection after splenectomy. BMJ 331 (2005) 417-418
6. Siber G.R., Ambrosino D.M., McIver J., Ervin T.J., Schiffman G., Sallan S., et al. Preparation of human hyperimmune globulin to Haemophilus influenza b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun 45 (1984) 248-254
7. Goldblatt D., Levinsky R.J., and Turner M.W. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood. J Infect Dis 166 (1992) 632-634
8. Herrmann D.J., Hamilton R.G., Barington T., Frasch C.E., Arakere G., Mäkelä O., et al. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods 148 (1992) 101-114
9. Konradsen H.B., Sorensen U.B., and Henrichsen J. A modified enzyme-linked immunosorbent assay for measuring type-specific antipneumococcal capsular polysaccharide antibodies. J Immunol Methods 164 1 (1993) 13-20
10. Wernette C.M., Frasch C.E., Madore D., Carlone G., Goldblatt D., Plikaytis B., et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 10 4 (2003) 514-519
11. World Health Organization. Pneumococcal conjugate vaccines Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Tech Rep Ser 927; Annex 2; 2005, p. 64-98.
12. Rijkers G.T., Sanders L.A., and Zegers B.J. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 5 1 (1993) 1-21
13. Käyhty H., Peltola H., Karanko V., and Mäkelä P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus Influenzae type b. J Infect Dis 147 6 (1983) 1100
14. Centers for disease control and prevention. Prevention and control of Meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54:1-21.
15. Davies J.M., Barnes R., and Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med JRPCL 2 (2002) 440-443
16. Hazlewoord M., and Kumararatne D.S. The spleen? Who needs it anyway? Editorial Review. Clin Exp Immunol 89 (1992) 327-329
17. Melles D.C., and Marie de S. Prevention of infections in hyposplenic and asplenic patients: an update. Neth J Med 62 2 (2004) 45-52
18. Recommendations of the Immunization Practices Advisory Committee (ACIP) Update: Pneumococcal Polysaccharide Vaccine Usage-United States. MMWR 1984;33(20):273-276,281.
19. Spickett G.P., Bullimore J., Wallis J., Smith S., and Saunders P. Northern region asplenia register-analysis of first two years. J Clin Pathol 52 (1999) 424-429
20. Kind E.A., Craft C., Fowles J.B., and McCoy C.E. Pneumococcal vaccine administration associated with splenectomy: missed opportunities. Am J Infect Control 26 (1998) 418-422
21. Kinnersley P., Wilkinson C.E., and Srinivasan J. Pneumococcal vaccination after splenectomy: survey of hospital and primary care records. BMJ 307 (1993) 1398-1399
22. Brigden M.L., Pattullo A., and Brown G. Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist. Am J Hematol 65 (2000) 25-29
23. Hosea S.W., Burch C.G., Brown E.J., Berg R.A., and Frank M.M. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. The Lancet 1 8224 (1981) 804-807
24. Stoehr G.A., Rose M.A., Eber S.W., Heidemann K., Schubert R., and Zielen S. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomized for hereditary spherocytosis. Br J Haematol 132 (2005) 788-790
25. Breukels M.A., Zandvoort A., van den Dobbelsteen G.P., van den Muijsenberg A., Lodewijk M.E., Beurret M., et al. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides. Infect Immunity 69 12 (2001) 7583-7587
26. Musher D.M., Ceasar H., Kojic E.M., Musher B.L., Gathe Jr. J.C., Romero-Steiner S., et al. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. JID 191 (2005) 1063-1067